October 23, 2016 1:17 PM ET


Company Overview of Amplyx Pharmaceuticals, Inc.

Executive Profile

Michael G. Grey

Chief Executive Officer and President, Amplyx Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 15 different industries.

See Board Relationships


Mr. Michael G. Grey, also known as Mike, has been a Venture Partner at Pappas Ventures since January 11, 2010 and a Venture Partner at Pappas Capital, LLC since January 2010. Mr. Grey serves as the Chief Executive Officer and President at Amplyx Pharmaceuticals, Inc. He serves as Executive Chairman of Ziarco Pharma Ltd. He is also the Founder, Chairman, and Chief Executive Officer at Reneo Pharmaceuticals, Inc. He was a Co-Founder of Lumena Pharmaceuticals, Inc., and ...

Corporate Headquarters

1505 Chestnut Street
San Carlos, California 94070

United States

Phone: 415-578-3263
Fax: 617-507-2691

Board Members Memberships

Executive Chairman
Independent Director, Chairman of Compensation Committee and Member of Science & Technology Committee
Lead Independent Director, Member of Transaction Committee and Member of Compensation Committee
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee


BS 1974
Nottingham University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Amplyx Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.